NCT05305391View on ClinicalTrials.gov

Low-grade Inflammation and Gut Symptoms From A2 and Hydrolyses A1 Milk

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

March 3, 2023

Study Completion Date

March 3, 2023

Conditions
Milk Intolerance
Interventions
OTHER

Dietary intervention

The arising gastrointestinal symptoms and inflammation markers from consumption of milk + lactase capsule / placebo.

Trial Locations (1)

20500

Food Chemistry and Food Development, Department of Life Technologies, University of Turku, Turku

All Listed Sponsors
lead

University of Turku

OTHER